Citation 61063

ISONO,K: URAMOTO,M: KUSAKABE,H: KIMURA,K-I: IZAKI,K: NELSON,CC: MC CLOSKEY,JA:. (1985). LIPOSIDOMYCINS: NOVEL NUCLEOSIDE ANTIBIOTICS WHICH INHIBIT BACTERIAL PEPTIDOGLYCAN SYNTHESIS.. 38(11)

Citation Details

TitleLIPOSIDOMYCINS: NOVEL NUCLEOSIDE ANTIBIOTICS WHICH INHIBIT BACTERIAL PEPTIDOGLYCAN SYNTHESIS.
AuthorsISONO,K: URAMOTO,M: KUSAKABE,H: KIMURA,K-I: IZAKI,K: NELSON,CC: MC CLOSKEY,JA:
Year1985
Volume38
Issue11

Summary

Year: 1985

Journal: Unknown

Organisms and Their Experiments (1)

Streptomyces griseosporeus (STREPTOMYCETACEAE)

Experiment #Pharmacology TypeWorktypesCompoundResults
1Not specified
UV SPECTRUM GIVEN FORION EXCHANGE METHODS USEDMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDHPLC DATA REPORTEDGEL PERMEATION CHROMATOGRAPHY USEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
LIPOSIDOMYCIN A
None
2
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
LIPOSIDOMYCIN A
ACTIVE
3
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
LIPOSIDOMYCIN A
INACTIVE
4
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
LIPOSIDOMYCIN A
WEAK ACTIVITY
5
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
LIPOSIDOMYCIN A
INACTIVE
6
ANTIMYCOBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
LIPOSIDOMYCIN A
ACTIVE
7
PEPTIDOGLYCAN SYNTHESIS INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
LIPOSIDOMYCIN A
ACTIVE
8
TOXIC EFFECT(GENERAL)
TOXICITY MARKER CODEPHARMACOLOGY OF COMPOUND - IN VIVO
LIPOSIDOMYCIN A
INACTIVE
9Not specified
UV SPECTRUM GIVEN FORION EXCHANGE METHODS USEDMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDHPLC DATA REPORTEDGEL PERMEATION CHROMATOGRAPHY USEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
LIPOSIDOMYCIN B
None
10
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
LIPOSIDOMYCIN B
WEAK ACTIVITY
11
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
LIPOSIDOMYCIN B
INACTIVE
12
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
LIPOSIDOMYCIN B
WEAK ACTIVITY
13
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
LIPOSIDOMYCIN B
INACTIVE
14
ANTIMYCOBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
LIPOSIDOMYCIN B
ACTIVE
15
PEPTIDOGLYCAN SYNTHESIS INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
LIPOSIDOMYCIN B
ACTIVE
16
TOXIC EFFECT(GENERAL)
TOXICITY MARKER CODEPHARMACOLOGY OF COMPOUND - IN VIVO
LIPOSIDOMYCIN B
INACTIVE
17Not specified
UV SPECTRUM GIVEN FORION EXCHANGE METHODS USEDMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDHPLC DATA REPORTEDGEL PERMEATION CHROMATOGRAPHY USEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
LIPOSIDOMYCIN C
None
18
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
LIPOSIDOMYCIN C
WEAK ACTIVITY
19
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
LIPOSIDOMYCIN C
INACTIVE
20
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
LIPOSIDOMYCIN C
WEAK ACTIVITY
21
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
LIPOSIDOMYCIN C
INACTIVE
22
ANTIMYCOBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
LIPOSIDOMYCIN C
ACTIVE
23
PEPTIDOGLYCAN SYNTHESIS INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
LIPOSIDOMYCIN C
ACTIVE
24
TOXIC EFFECT(GENERAL)
TOXICITY MARKER CODEPHARMACOLOGY OF COMPOUND - IN VIVO
LIPOSIDOMYCIN C
INACTIVE
Show SPARQL Queries (1)